Challenges associated with chronic aortic dissections: single-center experience of iliac branch devices in chronic

David Khangholi1, Christos Vrettos1, Nikolaos Konstantinou1

  • 1Department of Vascular Surgery, University Hospital Munich, LMU Munich, München, Germany.

Insights

Iliac branch devices (IBDs) show high technical success for chronic aortic dissections, leading to significant aneurysm shrinkage and preserved pelvic perfusion. Despite off-label use, outcomes are acceptable in experienced centers, though complications highlight the need for careful perioperative care.

Area of Science:

  • Vascular Surgery
  • Endovascular Interventions
  • Aortic Aneurysm Treatment

Background:

  • Chronic aortic dissections extending into iliac arteries pose significant anatomical and procedural challenges.
  • Iliac branch devices (IBDs) offer a potential solution for preserving pelvic perfusion and excluding the false lumen in these complex cases.
  • Current use of IBDs in dissected aortoiliac anatomy is off-label and requires further investigation.

Purpose of the Study:

  • To evaluate the safety, technical success, and mid-term outcomes of using IBDs in patients with chronic post-dissection aneurysms.
  • To assess aneurysm remodeling and preservation of pelvic perfusion following IBD implantation.
  • To identify factors influencing mortality, endoleaks, occlusions, and reinterventions.

Main Methods:

  • Retrospective single-center study of patients treated with IBDs for chronic aortoiliac dissections (2016-2024).
  • Analysis of preoperative anatomy, procedural details, and clinical outcomes including technical success, aneurysm shrinkage, mortality, endoleaks, occlusions, and reinterventions.
  • Primary endpoints: technical success and aneurysm shrinkage. Secondary endpoints: mortality, IBD-related complications, and reinterventions.

Main Results:

  • 100% technical success in 38 IBD implantations across 28 patients; 53% performed with f/bEVAR.
  • Significant aneurysm shrinkage observed in all segments (aorta, bifurcation, CIA) (P≤0.004).
  • 36-month freedom from endoleak: 76%, occlusion: 91%, reintervention: 75%. Overall survival: 96% at 12 months, 86% at 36 months, 62% at 60 months. Four IBD occlusions and eight reinterventions occurred.

Conclusions:

  • IBDs demonstrate high technical success, favorable aneurysm remodeling, and sustained pelvic perfusion in complex chronic aortic dissections.
  • Off-label use of IBDs in experienced centers yields acceptable complication rates, though clinical complications (39%) necessitate meticulous perioperative care.
  • Further prospective multicenter studies are essential for optimizing patient selection, device design, and validating these findings.
Abstract